Lijun Jia

13.1k citations
92 papers · 3.0k indexed · h-index 29
Topics
Ubiquitin and proteasome pathways (47 papers)Cancer-related Molecular Pathways (19 papers)Autophagy in Disease and Therapy (17 papers)
Journals
Journal of Clinical InvestigationNature CommunicationsSHILAP Revista de lepidopterología

In The Last Decade

Lijun Jia

90 papers receiving 3.0k citations

Peers

Lijun Jia
Comparison fields: 5 of 105
  • Molecular Biology 2.3k
  • Oncology 937
  • Epidemiology 506
  • Cancer Research 503
  • Cell Biology 323
Replace Yoshitaka Hippo with:
Yoshitaka Hippo Japan
Christina Voelkel‐Johnson United States
Darjus F. Tschaharganeh Germany
Nelofer Syed United Kingdom
Dimitris Athineos United Kingdom
Clint Mitchell United States
Go J. Yoshida Japan
Mingjia Tan United States
Narendra Wajapeyee United States
Susan Mason United Kingdom
Lijun Jia relative to Yoshitaka Hippo Japan Yoshitaka Hippo's profile →
Citations per field
00.5×2.9×
Yoshitaka Hippo · 1×
Citations per year

Countries citing papers authored by Lijun Jia

Since Specialization
Citations

This map shows the geographic impact of Lijun Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Jia more than expected).

Fields of papers citing papers by Lijun Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijun Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Jia. The network helps show where Lijun Jia may publish in the future.

Co-authorship network of co-authors of Lijun Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Lijun Jia. A scholar is included among the top collaborators of Lijun Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijun Jia. Lijun Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 2
4 8
5 11
6 19
7 3
8 3
9 5
10 7
11 15
12 21
13 21
14 17
15 74
16 202
17 81
18 83
19 109
20 52

About Lijun Jia

Lijun Jia is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 92 papers that have together received 3.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (47 papers), Cancer-related Molecular Pathways (19 papers) and Autophagy in Disease and Therapy (17 papers). The work is most often cited by research in Oncology (937 citations), Molecular Biology (2.3k citations) and Cancer Research (503 citations). Lijun Jia has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yi Sun, Lisha Zhou, Lihui Li, Wenjuan Zhang, Yanyu Jiang, Hua Li, Yongchao Zhao, Lak Shin Jeong, Xiufang Xiong and Qin Luo. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026